Skip to main content

What Ever Happened to Stem Cells?

February 18, 2016

In this webinar we discuss the different kinds of stem cells (embryonic and induced pluripotent stem cells) and how researchers are using these tools to learn more about Parkinson's disease and develop new treatments.

Webinar Details


Thursday, February 18, 2016


1 hr


12:00 pm ET
  • Continuing Medical Education Information

    MJFF offers Continuing Medical Education (CME) credit for practicing health care professionals for each Third Thursday Webinar. Click the link in the Resource List after viewing the webinar to take the post-test survey and receive your CME credit.

    Date of Original Release: February 18, 2016
    Date CME Credit No Longer Available: February 18, 2018

    Learning Objectives

    At the conclusion of this course, participants should be able to:

    • Define the role of stem cells.
    • Discuss the differences between embryonic and adult stem cells.
    • Describe induced pluripotent stem cells and how they are created.
    • Summarize previous research efforts in Parkinson's disease involving stem cells.
    • Identify how stem cells could potentially be used to treat Parkinson's disease symptoms.
    • Recognize how stem cells could potentially be used to learn more about the pathophysiology of Parkinson's disease.
    Target Audience

    This educational activity is designed for primary care physicians, family practice physicians, general medicine physicians, geriatricians, general neurologists, movement disorder specialists and any other health care practitioners who manage patients with Parkinson's disease.


    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of Oakstone Publishing, LLC and The Michael J. Fox Foundation for Parkinson's Research. The Oakstone Publishing, LLC is accredited by the ACCME to provide continuing medical education for physicians.

    Oakstone Publishing, LLC designates this enduring material for 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


    Oakstone Publishing, LLC has assessed conflict of interest with its faculty, authors, editors and any individuals who were in a position to control the content of this CME activity. Any identified relevant conflicts of interest were resolved for fair balance and scientific objectivity of studies utilized in this activity. Oakstone Publishing, LLC's planners, content reviewers, and editorial staff disclose no relevant commercial interests.


    Ole Isacson, MD-PhD
    Professor of Neurology/Neuroscience at Harvard Medical School
    Founding Director of the Neuroregeneration Research Institute/ Neuroregeneration Laboratories at McLean Hospital
    Principal Faculty of the Harvard Stem Cell Institute
    No disclosures

    Todd Sherer, PhD
    CEO, The Michael J. Fox Foundation
    No disclosures

    Dave Iverson
    No disclosures

We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.